Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 20;13(14):2426.
doi: 10.3390/diagnostics13142426.

Machine-Learning-Based Diagnostics of Cardiac Sarcoidosis Using Multi-Chamber Wall Motion Analyses

Affiliations

Machine-Learning-Based Diagnostics of Cardiac Sarcoidosis Using Multi-Chamber Wall Motion Analyses

Jan Eckstein et al. Diagnostics (Basel). .

Abstract

Background: Hindered by its unspecific clinical and phenotypical presentation, cardiac sarcoidosis (CS) remains a challenging diagnosis.

Objective: Utilizing cardiac magnetic resonance imaging (CMR), we acquired multi-chamber volumetrics and strain feature tracking for a support vector machine learning (SVM)-based diagnostic approach to CS.

Method: Forty-five CMR-negative (CMR(-), 56.5(53.0;63.0)years), eighteen CMR-positive (CMR(+), 64.0(57.8;67.0)years) sarcoidosis patients and forty-four controls (CTRL, 56.5(53.0;63.0)years)) underwent CMR examination. Cardiac parameters were processed using the classifiers of logistic regression, KNN(K-nearest-neighbor), DT (decision tree), RF (random forest), SVM, GBoost, XGBoost, Voting and feature selection.

Results: In a three-cluster analysis of CTRL versus vs. CMR(+) vs. CMR(-), RF and Voting classifier yielded the highest prediction rates (81.82%). The two-cluster analysis of CTRL vs. all sarcoidosis (All Sarc.) yielded high prediction rates with the classifiers logistic regression, RF and SVM (96.97%), and low prediction rates for the analysis of CMR(+) vs. CMR(-), which were augmented using feature selection with logistic regression (89.47%).

Conclusion: Multi-chamber cardiac function and strain-based supervised machine learning provides a non-contrast approach to accurately differentiate between healthy individuals and sarcoidosis patients. Feature selection overcomes the algorithmically challenging discrimination between CMR(+) and CMR(-) patients, yielding high accuracy predictions. The study findings imply higher prevalence of cardiac involvement than previously anticipated, which may impact clinical disease management.

Keywords: cardiac magnetic resonance; cardiac sarcoidosis 3; cardiac strain; machine learning 2; multi-chamber analyses.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow chart illustrating the processing steps of machine learning along with the applied classifiers. CTRL—control subjects, CMR(+)—positive cardiac magnetic resonance patients, CMR(−)—negative cardiac magnetic resonance patients, KNN—K-nearest-neighbor, DT—deep trees, RF—random forest, SVM—support vector machine, GBOOST—gradient boosting, XGBOOST—extreme gradient boosting.
Figure 2
Figure 2
Graphic discrimination between classifier performance of the different analyses, yielding below (red) and above (green) 80% prediction rates with corresponding outcome statistics. CTRL—control subjects, CMR(+)—positive cardiac magnetic resonance patients, CMR(−)—negative cardiac magnetic resonance patients, All Sarc.—all sarcoidosis patients, KNN—K-nearest-neighbor, DT—deep trees, RF—random forest, SVM—support vector machine, GBOOST—gradient boosting, XGBOOST—extreme gradient boosting.
Figure 3
Figure 3
Selected confusion matrices for 36-feature analyses of the various cluster analyses, depicting the highest yielding classifier(s) per cluster with corresponding performance statistics. Precision—positive predictive value, recall score—sensitivity, F1-score—test accuracy, CTRL—control subjects, CMR(+)—positive cardiac magnetic resonance patients, CMR(−)—negative cardiac magnetic resonance patients, All Sarc.—all sarcoidosis patients, DT—deep trees, RF—random forest.
Figure 4
Figure 4
ROC curves for (A) CMR(+) vs. CMR(–) with no feature selection and (B) (+) v. CMR(–) after selecting features.

References

    1. Soto-Gomez N., Peters J.I., Nambiar A.M. Diagnosis and Management of Sarcoidosis. Am. Fam. Physician. 2016;93:840–848. - PubMed
    1. Hamzeh N., Steckman D.A., Sauer W.H., Judson M.A. Pathophysiology and clinical management of cardiac sarcoidosis. Nat. Rev. Cardiol. 2015;12:278–288. doi: 10.1038/nrcardio.2015.22. - DOI - PubMed
    1. Chow K.L., O’Donnell J.L., Crozier I. Prevalence, incidence and survival outcomes of cardiac sarcoidosis in the South Island, New Zealand. Int. J. Cardiol. 2022;357:128–133. doi: 10.1016/j.ijcard.2022.04.004. - DOI - PubMed
    1. Swigris J.J., Olson A.L., Huie T.J., Fernandez-Perez E.R., Solomon J., Sprunger D., Brown K.K. Sarcoidosis-related mortality in the United States from 1988 to 2007. Am. J. Respir. Crit. Care Med. 2011;183:1524–1530. doi: 10.1164/rccm.201010-1679OC. - DOI - PMC - PubMed
    1. Silverman K.J., Hutchins G.M., Bulkley B.H. Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation. 1978;58:1204–1211. doi: 10.1161/01.CIR.58.6.1204. - DOI - PubMed

LinkOut - more resources